VC-backed 10x Genomics buys Epinomics

Genomics company 10x Genomics has acquired Epinomics, a provider of epigenetic technology. No financial terms were disclosed. 10x Genomics' backers include Venrock, Softbank, Foresite Capital, Fidelity and Meritech Capital. And, Epinomics' backers included Lightspeed Venture Partners, Felicis Ventures and Founders Fund.

30 August 2018•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail